XML 70 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Net Revenues:        
Asset management and administration fees $ 572 $ 496 $ 1,124 $ 980
Interest revenue 499 497 996 969
Interest expense (26) (39) (54) (77)
Net interest revenue 473 458 942 892
Trading revenue 235 219 458 462
Other 59 [1] 121 [1] 115 [1] 167 [1]
Provision for loan losses 1 (4) (5) (4)
Net impairment losses on securities (3) [2] (7) [2] (7) [2] (25) [2]
Total net revenues 1,337 1,283 2,627 2,472
Expenses Excluding Interest        
Compensation and benefits 494 446 1,030 911
Professional services 106 93 205 189
Occupancy and equipment 77 80 154 156
Advertising and market development 67 57 141 124
Communications 56 55 110 113
Depreciation and amortization 51 48 102 96
Other 74 72 142 138
Total expenses excluding interest 925 851 1,884 1,727
Income before taxes on income 412 432 743 745
Taxes on income 156 157 281 275
Net Income 256 275 462 470
Preferred stock dividends 23 14 31 14
Net income available to Common Stockholders $ 233 $ 261 $ 431 $ 456
Weighted-Average Common Shares Outstanding - Diluted 1,288 [3] 1,274 [3] 1,285 [3] 1,273 [3]
Earnings Per Common Share - Basic $ 0.18 $ 0.20 $ 0.33 $ 0.36
Earnings Per Common Share - Diluted $ 0.18 $ 0.20 $ 0.33 $ 0.36
[1] Unallocated amount includes a pre-tax gain of $70 million relating to a confidential resolution of a vendor dispute in the second quarter of 2012
[2] Net impairment losses on securities include total other-than-temporary impairment losses of $2 million and $12 million, net of $(1) million and $5 million reclassified from or recognized in other comprehensive income, for the three months ended June 30, 2013 and 2012, respectively. Net impairment losses on securities include total other-than-temporary impairment losses of $2 million and $14 million, net of $(5) million and $(11) million reclassified from other comprehensive income, for the six months ended June 30, 2013 and 2012, respectively
[3] Antidilutive stock options and restricted stock awards excluded from the calculation of diluted EPS totaled 28 million and 59 million shares for the second quarters of 2013 and 2012, respectively, and 32 million and 61 million shares for the first halves of 2013 and 2012, respectively.